170 related articles for article (PubMed ID: 28097884)
1. The pretreatment thrombocytosis may predict prognosis of patients with colorectal cancer: a systematic review and meta-analysis.
Wang YH; Deng SJ; Yang YD; Yao N; Zhao JM; Min GT; Wang J; Xu TF; Zhao PY; Wang HP; Chen W
Biomark Med; 2017 Feb; 11(2):195-210. PubMed ID: 28097884
[TBL] [Abstract][Full Text] [Related]
2. Poor Prognosis Significance of Pretreatment Thrombocytosis in Patients with Colorectal Cancer: a Meta-Analysis.
Zhao JM; Wang YH; Yao N; Wei KK; Jiang L; Hanif S; Wang ZX
Asian Pac J Cancer Prev; 2016; 17(9):4295-4300. PubMed ID: 27797233
[TBL] [Abstract][Full Text] [Related]
3. The prognostic role of pretreatment platelet-to-lymphocyte ratio as predictors in patients with colorectal cancer: a meta-analysis.
Min GT; Wang YH; Yao N; Zhao JM; Wang J; Wang HP; Chen W; Deng SJ; Li YM
Biomark Med; 2017 Jan; 11(1):87-97. PubMed ID: 27917650
[TBL] [Abstract][Full Text] [Related]
4. Poor prognostic role of the pretreatment platelet counts in colorectal cancer: A meta-analysis.
Rao XD; Zhang H; Xu ZS; Cheng H; Shen W; Wang XP
Medicine (Baltimore); 2018 Jun; 97(23):e10831. PubMed ID: 29879017
[TBL] [Abstract][Full Text] [Related]
5. Thrombocytosis predicts poor prognosis of Asian patients with colorectal cancer: A systematic review and meta-analysis.
Xia S; Wu W; Yu L; Ma L; Chen S; Wang H
Medicine (Baltimore); 2022 Sep; 101(35):e30275. PubMed ID: 36107503
[TBL] [Abstract][Full Text] [Related]
6. Elevation of platelet count in patients with colorectal cancer predicts tendency to metastases and poor prognosis.
Lin MS; Huang JX; Zhu J; Shen HZ
Hepatogastroenterology; 2012 Sep; 59(118):1687-90. PubMed ID: 22591645
[TBL] [Abstract][Full Text] [Related]
7. The pretreatment thrombocytosis as one of prognostic factors for gastric cancer: A systematic review and meta-analysis.
Wang YH; Kang JK; Zhi YF; Zhang Y; Wang ZQ; Zhou Q; Niu WY; Ma MJ
Int J Surg; 2018 May; 53():304-311. PubMed ID: 29654963
[TBL] [Abstract][Full Text] [Related]
8. Thrombocytosis Portends Adverse Prognosis in Colorectal Cancer: A Meta-Analysis of 5,619 Patients in 16 Individual Studies.
Gu D; Szallasi A
Anticancer Res; 2017 Sep; 37(9):4717-4726. PubMed ID: 28870890
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of pretreatment thrombocytosis in gastric cancer: A systematic review and meta-analysis.
Yang C; Jiang H; Huang S; Hong H; Huang X; Wang X; Liao W; Wang X; Chen X; Jiang L
Medicine (Baltimore); 2018 Aug; 97(31):e11763. PubMed ID: 30075601
[TBL] [Abstract][Full Text] [Related]
10. Is there a role for pre-operative thrombocytosis in the management of colorectal cancer?
Nyasavajjala SM; Runau F; Datta S; Annette H; Shaw AG; Lund JN
Int J Surg; 2010; 8(6):436-8. PubMed ID: 20685408
[TBL] [Abstract][Full Text] [Related]
11. Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer.
Sasaki K; Kawai K; Tsuno NH; Sunami E; Kitayama J
World J Surg; 2012 Jan; 36(1):192-200. PubMed ID: 22045447
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of pretreatment elevated platelet count in patients with colorectal cancer: a meta-analysis.
Long Y; Wang T; Gao Q; Zhou C
Oncotarget; 2016 Dec; 7(49):81849-81861. PubMed ID: 27833087
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of thrombocytosis as predictive factor in colorectal cancer].
Baranyai Z; Jósa V; Krzystanek M; Eklund AC; Szász AM; Szállási Z
Magy Seb; 2013 Dec; 66(6):331-7. PubMed ID: 24333978
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of pretreatment thrombocytosis on survival in patients with cervical cancer: a systematic review and meta-analysis.
Cao W; Yao X; Cen D; Zhi Y; Zhu N; Xu L
World J Surg Oncol; 2019 Aug; 17(1):132. PubMed ID: 31375109
[TBL] [Abstract][Full Text] [Related]
15. The association of pretreatment thrombocytosis with prognosis and clinicopathological significance in cervical cancer: a systematic review and meta-analysis.
Cheng J; Zeng Z; Ye Q; Zhang Y; Yan R; Liang C; Wang J; Li M; Yi M
Oncotarget; 2017 Apr; 8(15):24327-24336. PubMed ID: 28212582
[TBL] [Abstract][Full Text] [Related]
16. The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer.
Baranyai Z; Krzystanek M; Jósa V; Dede K; Agoston E; Szász AM; Sinkó D; Szarvas V; Salamon F; Eklund AC; Szállási Z; Jakab F
Thromb Haemost; 2014 Mar; 111(3):483-90. PubMed ID: 24285160
[TBL] [Abstract][Full Text] [Related]
17. The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysis.
Zhang J; Zhang HY; Li J; Shao XY; Zhang CX
Oncotarget; 2017 Sep; 8(40):68837-68846. PubMed ID: 28978160
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment thrombocytosis as a significant prognostic factor in malignant mesothelioma: a meta-analysis.
Zhuo Y; Lin L; Zhang M
Platelets; 2017 Sep; 28(6):560-566. PubMed ID: 27848258
[TBL] [Abstract][Full Text] [Related]
19. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
Todenhöfer T; Renninger M; Schwentner C; Stenzl A; Gakis G
BJU Int; 2012 Dec; 110(11 Pt B):E533-40. PubMed ID: 22578156
[TBL] [Abstract][Full Text] [Related]
20. Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma.
Shimada H; Oohira G; Okazumi S; Matsubara H; Nabeya Y; Hayashi H; Takeda A; Gunji Y; Ochiai T
J Am Coll Surg; 2004 May; 198(5):737-41. PubMed ID: 15110807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
